Enhancing Oncology Model (EOM) Fact Sheet
Download to see features of the new healthcare delivery model and value-based care payment system for oncology practices, administered by the Centers for Medicare and Medicaid Services (CMS).
Enhancing Oncology Model (EOM) White Paper: Perspectives from Oncology Practices and the Path Forward in Value-Based Care
To gather early perceptions of the EOM and understand how oncology practices evaluated participation decisions in the new model, Magnolia facilitated an advisory panel discussion with key opinion leaders.
Developing strategic game plans in response to shifts in federal policy
Biopharmaceutical companies engaged Magnolia to help them understand the implications of the Inflation Reduction Act of 2022 and develop long-term strategic plans to adjust for the sweeping market changes it will cause.
Providing program management support in the lead-up to NDA submission and launch
A development-stage biopharma company engaged Magnolia to help put in place an overarching launch road map for a drug that had just received positive phase 3 data.
Designing a coding gameplan for a soon-to-launch infused biologic
A biopharma company needed an inpatient coding analysis for their new medication.
Realigning the Hub
A pharmaceutical company offering a hub designed to address patient medication access challenges received customer feedback expressing dissatisfaction from both patients and providers.
Lining up support for a New Technology Add-on Payment in a rare-disease treatment
A biopharma company wanted to know the likelihood of receiving an NTAP after launching an inpatient treatment.
FY24 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH) Proposed Rule
Download to see features of the proposed rule.
Using published evidence and compendia to support expanded coverage for an off-label medication dosage
A pharma company needed to evaluate the likelihood that drug compendia would positively rate an off-label dosage of an FDA-approved medication to support additional payer coverage.